Outcome of CPAP Titration for Moderate-to-Severe OSA Under Drug-Induced Sleep Endoscopy: A Randomized Controlled Crossover Trial
- PMID: 35769360
- PMCID: PMC9234400
- DOI: 10.3389/fneur.2022.882465
Outcome of CPAP Titration for Moderate-to-Severe OSA Under Drug-Induced Sleep Endoscopy: A Randomized Controlled Crossover Trial
Abstract
Background: The titration pressure of continuous positive airway pressure (CPAP) is important in patients with obstructive sleep apnea (OSA). This study aimed to understand the difference between drug-induced sleep endoscopy (DISE)-guided CPAP titration and conventional sleep center (CSC) CPAP titration in patients with OSA.
Methods: In this randomized, controlled, and single-blind crossover trial, we compared the effects of 1-month CPAP treatment in patients with OSA with either DISE-guided CPAP titration or CSC CPAP titration. Twenty-four patients with OSA were recruited for the study. All patients underwent polysomnography, DISE-guided CPAP titration, and accommodation. Initially, patients were randomly assigned to receive either DISE-guided CPAP titration or CSC CPAP treatment for the first month. They were then switched to other treatments in the second month. The Epworth sleepiness scale (ESS) score was recorded at baseline, 1 and 2 months.
Results: The upper limit of the pressure of DISE-guided titration and CSC CPAP titration was not significantly different (13.9 ± 0.7 vs. 13.5 ± 0.5 cm H2O; P = 0.92). The residual apnea-hypopnea index and compliance were also not significantly different between the groups. ESS score significantly improved from baseline to 1 month after CPAP treatment in both groups. Both epiglottis (anterior-posterior collapse) and tongue base collapse were significantly associated with 95% CPAP pressure (P = 0.031 and 0.038, respectively). After multivariate regression analyses, the epiglottis (anterior-posterior collapse) was an independent factor for 95% CPAP pressure. The incidence rate of bradycardia was 58.3%, which is a safety concern for DISE. Despite the high incidence of bradycardia, all patients with bradycardia recovered with proper management.
Conclusion: Both modalities were comparable in terms of establishing the pressure settings required to treat patients. Further large-scale studies are required to confirm these results.
Trial registration: https://clinicaltrials.gov/, NCT03523013.
Keywords: CPAP; CPAP pressure; OSA; drug-induced sleep endoscopy (DISE); outcome.
Copyright © 2022 Wang, Huang, Lin, Ni and Lo.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
The predictive value of drug-induced sleep endoscopy for CPAP titration in OSA patients.Sleep Breath. 2018 Dec;22(4):949-954. doi: 10.1007/s11325-017-1600-8. Epub 2017 Dec 15. Sleep Breath. 2018. PMID: 29247295
-
Drug-induced sleep endoscopy-continuous positive airway pressure (DISE-CPAP), a newer modality to choose the right candidates for CPAP.Sleep Breath. 2023 Oct;27(5):1787-1794. doi: 10.1007/s11325-023-02787-3. Epub 2023 Feb 8. Sleep Breath. 2023. PMID: 36753005
-
Continuous Positive Airway Pressure Titration During Pediatric Drug Induced Sleep Endoscopy.Ann Otol Rhinol Laryngol. 2022 Oct;131(10):1085-1091. doi: 10.1177/00034894211055527. Epub 2021 Oct 27. Ann Otol Rhinol Laryngol. 2022. PMID: 34706588
-
Continuous Positive Airway Pressure vs Mandibular Advancement Devices in the Treatment of Obstructive Sleep Apnea: An Updated Systematic Review and Meta-Analysis.Cureus. 2022 Jan 31;14(1):e21759. doi: 10.7759/cureus.21759. eCollection 2022 Jan. Cureus. 2022. PMID: 35251830 Free PMC article. Review.
-
Predictors of the Efficacy for Daytime Sleepiness in Patients With Obstructive Sleep Apnea With Continual Positive Airway Pressure Therapy: A Meta-Analysis of Randomized Controlled Trials.Front Neurol. 2022 Jun 27;13:911996. doi: 10.3389/fneur.2022.911996. eCollection 2022. Front Neurol. 2022. PMID: 35832171 Free PMC article.
Cited by
-
A Narrative Review of the Clinical Trials in Sleep-Related Breathing Disorders from 2022 to Present.Thorac Res Pract. 2023 Nov 28;25(1):42 - 49. doi: 10.5152/ThoracResPract.2023.23104. Thorac Res Pract. 2023. PMID: 38015164 Free PMC article.
References
Associated data
LinkOut - more resources
Full Text Sources
Medical